semaglutide oral obesity For patients with #obesity, semaglutide, a glucagon-like peptide-1 receptor agonist, is approved for weight management as a once-weekly subcutaneous injection. In a previous trial, at a dose of 50 mg Oral Semaglutide under Human Protocols

This webinar with obesity medicine physician Jonathan Bonnet, MD, MPH, a GLP-1RA expert, will answer all your questions about the medications, how they work, their benefits, their side effects, and how they can be combined with lifestyle changes to optimize your weight loss and body composition.

A closer look at what berberine actually does and why the comparison to semaglutide doesnt hold up

Calcium is essential for bone health, muscle function, nerve signaling, and blood clotting

Foundayo is a once daily oral treatment for adults with obesity or overweight with weight-related medical problems.

We are proud to share that Professor Jens Juul Holst from the Department of Biomedical Sciences has been awarded the Lipid Science Prize 2026 by the Camurus Lipid Research Foundation in Malm. Jens receives the prize in recognition of his groundbreaking discovery of the GLP1 hormone back in 1986 - a finding that laid the foundation for diabetes and weightloss medications used by millions worldwide